For example, there are several reports suggesting that low TSP-1 expression is correlated with increases in malignant aggressiveness and poorer outcomes in several cancers, including bladder cancer, prostate cancer, and renal cell carcinoma [14,22,27,28]. This evidence concerns the gene THBS1 and urinary bladder carcinoma.